, Tracking Stock Market Picks
Enter Symbol:

down 85.66 %

ASPENBIO PHARMA INC (APPY) rated Buy with price target $6 by Aegis Capital

Posted on: Friday,  Jan 4, 2013  10:25 AM ET by Aegis Capital

Aegis Capital rated Buy ASPENBIO PHARMA INC (NASDAQ: APPY) on 01/04/2013, when the stock price was $2.79. Since
then, ASPENBIO PHARMA INC has lost 85.66% as of 09/10/2015's recent price of $0.40.
If you would have followed this Aegis Capital's recommendation on APPY, you would have lost 85.66% of your investment in 979 days.

AspenBio Pharma, Inc. (AspenBio) is a biotechnology company engaged in the discovery, development, manufacture, and licensing or marketing of products. The Company is primarily focused on advancing towards commercialization its blood-based human diagnostic test, AppyScore to aid in the diagnosis of human appendicitis and several reproduction drugs for use in high value animals. AppyScore is a blood-based test to the aid in diagnosis of appendicitis. AppyScore measures the abundance of MRP 8/14, an inflammation biomarker, which AspenBio has identified to be elevated in acute appendicitis and demonstrates a correlation to the severity of the disease. In December 2008, the Company completed an 800 patient pivotal clinical trial for AppyScore. Products in its pipeline consist of product candidates in various stages of clinical and pre-clinical development.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/4/2013 10:25 AM Buy
2.79 6.00
as of 12/13/2013
1 Week down  -5.72 %
1 Month up  13.83 %
3 Months up  1.68 %
1 YTD down  -35.12 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy